TIRZEPATIDE

Tirzepatide

Dual Agonist | GIP • GLP-1

Tirzepatide is a dual incretin receptor agonist engineered to activate both GIP and GLP-1 receptors, providing coordinated metabolic signaling across multiple physiological pathways. Designed for advanced research applications, it supports investigation into glucose regulation, insulin signaling, energy homeostasis, and weight-related metabolic mechanisms.

 ________________________________________

Specifications

• Form: Lyophilized powder Freeze-dried powder form for stable storage and easy reconstitution.

• Quantity: 20 mg per vial 

• 99% Purity – HPLC Tested

________________________________________

Handling & Storage

Store in a cool, dry place away from light. Refrigeration required after reconstitution store between 5-8 degrees

________________________________________ 

Quality Standard 

Lab Tested and Manufactured under controlled conditions and supplied as research-grade material.

________________________________________ 

Shipping

Express shipping available within Australia.